Morgan Stanley’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$151K Buy
2025
Q1
$47K Sell
2024
Q4
$123K Buy
2024
Q3
Sell
2024
Q2
$1.68K Hold
2024
Q1
$2.73K Sell
2023
Q4
$2.36K Buy
2023
Q1
Sell
2022
Q4
$5 Hold
2022
Q3
$0 Buy